Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-14, Stock:JNJ, The news for the past five days is as follows:
2019-11-07: NEWS1: Teva climbs despite earnings miss.NEWS2: Peter Thiel’s VC Firm Is Sued by Its Former Top Lawyer.NEWS3: Biotech Stock On The Radar: Alkermes At A Crossroads.NEWS4: Teva and Other Opioid Defendant Stocks Jump on Strong Earnings.NEWS5: Special Report: How plaintiff lawyers help corporate America keep its secrets.NEWS6: Geron (GERN) Q3 Earnings Beat Estimates, Stock Gains 4.1%.NEWS7: UPDATE 1-Johnson & Johnson files for European approval of Ebola vaccine.
2019-11-08: NEWS1: Why It Could Soon Be Time To Take Profits In This Highflying Biotech Stock.NEWS2: Pacira's (PCRX) Q3 Earnings Top Estimates, Revenues Rise Y/Y.NEWS3: Pharma Stock Roundup: AGN, NVO Q3 Earnings, FDA Nod to SNY & NVS' Products.NEWS4: Nan Goldin on art, addiction and her battle with the Sacklers over opioids.NEWS5: What Happened at Mithril When Peter Thiel Wasn’t Around.
2019-11-11: NEWS1: The Zacks Analyst Blog Highlights: Novo Nordisk, Allergan, Sanofi, Novartis and J&J.NEWS2: AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL.
2019-11-12: NEWS1: Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc..
2019-11-13: NEWS1: UPDATE 1-J&J blockbuster loses ground to biosimilars despite Quebec court ruling.NEWS2: Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?.NEWS3: UPDATE 1-N.Y. insurance regulator notifies opioid makers, distributors of enforcement action -sources.NEWS4: Halozyme (HALO) Earnings & Revenues Miss Estimates in Q3.NEWS5: J&J's Remicade losing ground in Quebec health plan despite court victory.

Answer: Decrease